• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过荧光激活细胞分选分离成大小富集群体的高度聚集抗体的物理表征和体外生物学影响。

Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.

作者信息

Telikepalli Srivalli, Shinogle Heather E, Thapa Prem S, Kim Jae Hyun, Deshpande Meghana, Jawa Vibha, Middaugh C Russell, Narhi Linda O, Joubert Marisa K, Volkin David B

机构信息

Department of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas, 66047.

出版信息

J Pharm Sci. 2015 May;104(5):1575-91. doi: 10.1002/jps.24379. Epub 2015 Mar 5.

DOI:10.1002/jps.24379
PMID:25753756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4448733/
Abstract

An IgG2 monoclonal antibody (mAb) solution was subjected to stirring, generating high concentrations of nanometer and subvisible particles, which were then successfully size-enriched into different size bins by low-speed centrifugation or a combination of gravitational sedimentation and fluorescence-activated cell sorting (FACS). The size-fractionated mAb particles were assessed for their ability to elicit the release of cytokines from a population of donor-derived human peripheral blood mononuclear cells (PBMC) at two phases of the immune response. Fractions enriched in nanometer-sized particles showed a lower response than those enriched in micron-sized particles in this assay. Particles of 5-10 μm in size displayed elevated cytokine release profiles compared with other size ranges. Stir-stressed mAb particles had amorphous morphology, contained protein with partially altered secondary structure, elevated surface hydrophobicity (compared with controls), and trace levels of elemental fluorine. FACS size-enriched the mAb particle samples, yet did not notably alter the overall morphology or composition of particles as measured by microflow imaging, transmission electron microscopy, and scanning electron microscopy-energy dispersive X-ray spectroscopy. The utility and limitations of FACS for size separation of mAb particles and potential of in vitro PBMC studies to rank-order the immunogenic potential of various types of mAb particles are discussed.

摘要

将一种IgG2单克隆抗体(mAb)溶液进行搅拌,产生高浓度的纳米级和亚可见颗粒,然后通过低速离心或重力沉降与荧光激活细胞分选(FACS)相结合的方法成功地将其按大小富集到不同的尺寸区间。对按大小分级的mAb颗粒在免疫反应的两个阶段诱导供体来源的人外周血单核细胞(PBMC)释放细胞因子的能力进行了评估。在该实验中,富集纳米级颗粒的级分显示出比富集微米级颗粒的级分更低的反应。与其他尺寸范围相比,5-10μm大小的颗粒表现出更高的细胞因子释放谱。搅拌应激的mAb颗粒具有无定形形态,含有二级结构部分改变的蛋白质,表面疏水性升高(与对照相比),以及痕量的元素氟。FACS按大小富集了mAb颗粒样品,但通过微流成像、透射电子显微镜和扫描电子显微镜-能量色散X射线光谱法测量,并未显著改变颗粒的整体形态或组成。讨论了FACS在mAb颗粒大小分离中的实用性和局限性,以及体外PBMC研究对各种类型mAb颗粒免疫原性潜力进行排序的可能性。

相似文献

1
Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting.通过荧光激活细胞分选分离成大小富集群体的高度聚集抗体的物理表征和体外生物学影响。
J Pharm Sci. 2015 May;104(5):1575-91. doi: 10.1002/jps.24379. Epub 2015 Mar 5.
2
Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.液体IgG1抗体制剂中亚可见聚集体的无标记流式细胞术分析
J Pharm Sci. 2014 Jan;103(1):90-9. doi: 10.1002/jps.23782. Epub 2013 Nov 11.
3
Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.蛋白质亚可见颗粒制备分级分离的两种方法——差速离心法和荧光激活细胞分选法的比较评估
Pharm Res. 2015 Dec;32(12):3952-64. doi: 10.1007/s11095-015-1755-6. Epub 2015 Jul 21.
4
Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.IgG4 单克隆抗体稀释至不同静脉输注袋后的相容性、物理稳定性和特性。
J Pharm Sci. 2012 Oct;101(10):3636-50. doi: 10.1002/jps.23224. Epub 2012 Jun 25.
5
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.在各种应激条件下产生的IgG1单克隆抗体聚集体和颗粒的结构表征。
J Pharm Sci. 2014 Mar;103(3):796-809. doi: 10.1002/jps.23839. Epub 2014 Jan 22.
6
Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.利用微流成像数据更精确地计算亚可见蛋白质颗粒的质量。
J Pharm Sci. 2015 Feb;104(2):536-47. doi: 10.1002/jps.24156. Epub 2014 Oct 9.
7
Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice.皮下给予小鼠时,鼠源单克隆抗体亚微米颗粒比可溶性低聚体或微米颗粒具有更强的免疫原性。
J Pharm Sci. 2018 Nov;107(11):2847-2859. doi: 10.1016/j.xphs.2018.06.029. Epub 2018 Jul 10.
8
Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.评估气-溶液界面在机械搅拌引起的IgG1单克隆抗体亚可见颗粒形成机制中的作用。
J Pharm Sci. 2016 May;105(5):1643-1656. doi: 10.1016/j.xphs.2016.02.027. Epub 2016 Mar 26.
9
Aggregation of Recombinant Monoclonal Antibodies and Its Role in Potential Immunogenicity.重组单克隆抗体的聚集及其在潜在免疫原性中的作用。
Curr Pharm Biotechnol. 2018;19(4):343-356. doi: 10.2174/1389201019666180605130252.
10
Application of different analytical methods for the characterization of non-spherical micro- and nanoparticles.应用不同分析方法对非球形微纳米颗粒进行表征。
Int J Pharm. 2013 Sep 10;453(2):620-9. doi: 10.1016/j.ijpharm.2013.05.046. Epub 2013 May 29.

引用本文的文献

1
Impact of Monoclonal Antibody Aggregates on Effector Function Characterization.单克隆抗体聚集体对效应器功能表征的影响
Antibodies (Basel). 2025 Apr 2;14(2):31. doi: 10.3390/antib14020031.
2
Submicron immunoglobulin particles exhibit FcγRII-dependent toxicity linked to autophagy in TNFα-stimulated endothelial cells.亚微米免疫球蛋白颗粒在 TNFα 刺激的内皮细胞中表现出与自噬相关的 FcγRII 依赖性毒性。
Cell Mol Life Sci. 2024 Aug 30;81(1):376. doi: 10.1007/s00018-024-05342-9.
3
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展

本文引用的文献

1
Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.利用微流成像数据更精确地计算亚可见蛋白质颗粒的质量。
J Pharm Sci. 2015 Feb;104(2):536-47. doi: 10.1002/jps.24156. Epub 2014 Oct 9.
2
Conformational stability, reversibility and heat-induced aggregation of α-1-acid glycoprotein.α-1-酸性糖蛋白的构象稳定性、可逆性及热诱导聚集
J Biochem. 2014 Dec;156(6):345-52. doi: 10.1093/jb/mvu050. Epub 2014 Aug 20.
3
Freezing-induced perturbation of tertiary structure of a monoclonal antibody.
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
4
A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic.高生物治疗聚集物数量阈值是诱导体外、体内和临床免疫原性反应所必需的。
Pharm Res. 2024 Apr;41(4):651-672. doi: 10.1007/s11095-024-03678-2. Epub 2024 Mar 22.
5
Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates.自发性产生的治疗性单克隆抗体聚集体的免疫原性风险评估。
Front Immunol. 2022 Jul 27;13:915412. doi: 10.3389/fimmu.2022.915412. eCollection 2022.
6
Fcγ Receptor-Dependent Internalization and Off-Target Cytotoxicity of Antibody-Drug Conjugate Aggregates.Fcγ 受体依赖性抗体药物偶联物聚集物的内化和脱靶细胞毒性。
Pharm Res. 2022 Jan;39(1):89-103. doi: 10.1007/s11095-021-03158-x. Epub 2021 Dec 27.
7
Solubility Controlling Peptide Tags of Opposite Charges Generate a Bivalent Immune Response Against Dengue ED3 Serotypes 3 and 4.相反电荷的可溶性控制肽标签针对登革热 ED3 血清型 3 和 4 产生二价免疫反应。
Front Immunol. 2021 Jun 11;12:671590. doi: 10.3389/fimmu.2021.671590. eCollection 2021.
8
Particle Detection and Characterization for Biopharmaceutical Applications: Current Principles of Established and Alternative Techniques.生物制药应用中的颗粒检测与表征:现有技术和替代技术的当前原理
Pharmaceutics. 2020 Nov 19;12(11):1112. doi: 10.3390/pharmaceutics12111112.
9
T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation-Updated Consensus and Review 2020.T 细胞依赖性蛋白治疗药物免疫原性的临床前评估和缓解策略——2020 年更新共识和综述。
Front Immunol. 2020 Jun 30;11:1301. doi: 10.3389/fimmu.2020.01301. eCollection 2020.
10
Immunogenicity of Bioproducts: Cellular Models to Evaluate the Impact of Therapeutic Antibody Aggregates.生物制品的免疫原性:评估治疗性抗体聚集物影响的细胞模型。
Front Immunol. 2020 May 5;11:725. doi: 10.3389/fimmu.2020.00725. eCollection 2020.
冷冻诱导的单克隆抗体三级结构扰动
J Pharm Sci. 2014 Jul;103(7):1979-1986. doi: 10.1002/jps.24013. Epub 2014 May 15.
4
UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences.小鼠生长激素的紫外线光降解:化学分析及免疫原性后果
Eur J Pharm Biopharm. 2014 Jul;87(2):395-402. doi: 10.1016/j.ejpb.2014.04.005. Epub 2014 Apr 20.
5
Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro.人源重组单克隆抗体的聚集影响树突状细胞体外刺激适应性 T 细胞反应的能力。
PLoS One. 2014 Jan 21;9(1):e86322. doi: 10.1371/journal.pone.0086322. eCollection 2014.
6
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.在各种应激条件下产生的IgG1单克隆抗体聚集体和颗粒的结构表征。
J Pharm Sci. 2014 Mar;103(3):796-809. doi: 10.1002/jps.23839. Epub 2014 Jan 22.
7
Renewal of the air-water interface as a critical system parameter of protein stability: aggregation of the human growth hormone and its prevention by surface-active compounds.气-液界面的更新作为蛋白质稳定性的关键体系参数:人生长激素的聚集及其被表面活性剂化合物的抑制。
Langmuir. 2013 Dec 10;29(49):15240-50. doi: 10.1021/la4028223. Epub 2013 Nov 25.
8
Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.液体IgG1抗体制剂中亚可见聚集体的无标记流式细胞术分析
J Pharm Sci. 2014 Jan;103(1):90-9. doi: 10.1002/jps.23782. Epub 2013 Nov 11.
9
Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.雷达图阵列分析可视化制剂变量对多种分析技术测量的 IgG1 颗粒形成的影响。
J Pharm Sci. 2013 Dec;102(12):4256-67. doi: 10.1002/jps.23738. Epub 2013 Oct 9.
10
Ultraviolet spectroscopy as a tool in therapeutic protein development.紫外光谱法在治疗性蛋白开发中的应用。
J Pharm Sci. 2011 Apr;100(4):1214-27. doi: 10.1002/jps.22385. Epub 2010 Nov 24.